How large is the brain imaging devices market?

The market size of the brain imaging devices is estimated at USD 7.03 billion in 2027.

How will the brain imaging devices industry grow in terms of size and CAGR by 2036?

Brain Imaging Devices Market size was over USD 6.6 billion in 2026 and is likely to grow at a 7.79% CAGR between 2027 and 2036, surpassing USD 13.97 billion by 2036.

How is rising neurological disorder prevalence influencing investment priorities in advanced brain imaging systems?

Increasing cases of stroke, dementia, and neurodegenerative disorders are driving higher imaging volumes and earlier diagnostics. This pushes providers to invest in advanced MRI, CT, and PET systems that improve lesion detection, clinical decision speed, and monitoring across complex neurological workloads.

How are AI-enabled portable imaging systems changing deployment strategies in healthcare settings?

AI-enabled portable systems expand imaging access beyond fixed hospital infrastructure by supporting faster bedside assessment and triage. This enables decentralized deployment in outpatient and emergency settings, improving workflow efficiency and increasing adoption where specialist availability is limited.

Why do Devices account for the largest share of the brain imaging devices market?

Devices held a 77.43% share in 2026 because they form the core imaging platform used across hospitals and diagnostic centers, making them essential for routine clinical brain imaging workflows.

Why are Portable systems the fastest-growing modality in the brain imaging devices market?

Portable systems are growing fastest as healthcare providers seek flexible, point-of-care imaging that supports bedside assessments, faster decision-making, and improved access where patient movement is challenging.

Why does North America hold the largest share of the brain imaging devices market?

North America captured 41.55% of the market in 2026, supported by advanced hospitals, specialized diagnostic networks, strong imaging utilization, and established reimbursement and clinical infrastructure.

Which region is expected to experience the fastest growth in the brain imaging devices market?

Asia Pacific is projected to grow at a 9.27% CAGR as healthcare infrastructure expands, imaging installations increase, and more facilities adopt advanced diagnostic technologies for neurological care.

Who holds a significant market share in the brain imaging devices landscape?

Leading companies in the brain imaging devices market include GE HealthCare Technologies Inc. (United States), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Medtronic plc (Ireland), Nihon Kohden Corporation (Japan), Compumedics Limited (Australia), MEGIN Oy (Finland), Natus Medical Incorporated (United States), NeuroLogica Corporation (United States).